Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1999
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953356A1 Mitochondrial membrane stabilizer
11/03/1999EP0953355A1 Remedy for autoimmune diseases
11/03/1999EP0952855A1 Use of hyaluronan in gene therapy
11/03/1999EP0952845A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
11/03/1999EP0952842A2 A method of treating cancer
11/03/1999EP0952832A1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
11/03/1999EP0952827A1 Amino acid compositions and use thereof in immunosuppression
11/03/1999EP0952821A1 Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
11/03/1999EP0859595B1 Therapeutic preparation for the transdermal administration of active substances
11/03/1999CN1234072A Anti-ErbB2 antibodies
11/03/1999CN1233954A Taste-masked microcapsule compositions and method for mfg. same
11/03/1999CN1233953A Ascending-dose dosage form
11/03/1999CN1233476A Medicine for treating acute leukemia, and method for preparing same
11/02/1999US5977385 Method for the preparation of (+)-calanolide A and analogues thereof
11/02/1999US5977160 Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
11/02/1999US5977159 Medical use of an ace-inhibitor for treatment of dyspeptic symptoms
11/02/1999US5977143 Medicament against infertility which reduces phagocytosis of spermatozoa in women
11/02/1999US5977138 Alzheimer's disease
11/02/1999US5977099 Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
11/02/1999US5977088 Formulations containing hyaluronic acid
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976574 Forming a suspension; spray drying
11/02/1999US5976568 Total modular system of multivitamin and mineral supplementation composed of 7 distinct modules for improving public health by insuring adequate intake of micronutrients needed for disease prevention and protection against
11/02/1999US5976566 Non-steroidal antiinflammtory drug formulations for topical application to the skin
11/02/1999US5976565 Device for topical treatment of acne and its method of manufacture
11/02/1999US5976534 Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
10/1999
10/28/1999WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999WO1999054707A2 Fetal testing for prediction of low birth weight
10/28/1999WO1999054706A2 Method of treating interstitial cystitis with recombinant hb-egf
10/28/1999WO1999054481A1 Mutant having uracil phosphoribosyl transferase activity
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054445A2 Combination therapy using nucleic acids and conventional drugs
10/28/1999WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999WO1999053958A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999WO1999053953A2 Methods and products related to metabolic interactions in disease
10/28/1999WO1999053944A1 Method for treating the endotoxic shock in mammals
10/28/1999WO1999053925A1 Phytosterol formulations to lower cholesterol absorption
10/28/1999WO1999053921A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
10/28/1999WO1999053920A1 Use of vitamin pp compounds
10/28/1999WO1999053912A1 Topical immunostimulation to induce langerhans cell migration
10/28/1999WO1999053910A2 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
10/28/1999WO1999053906A1 Adhesive preparations
10/28/1999WO1999053899A1 Medicinal compositions for application to mucosa
10/28/1999WO1999053897A2 Topical formulation comprising poloxamers and further microbicides, and an applicator
10/28/1999WO1999053775A1 Propionibacterium p-63 for use in direct fed microbials for animal feeds
10/28/1999WO1999042839A3 Treating cancer
10/28/1999WO1999040946A3 Methods and compositions for modulating leptin activity
10/28/1999WO1999039740A3 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
10/28/1999WO1999037299B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/28/1999WO1999037150B1 Transcription therapy for cancers
10/28/1999WO1999035243A9 Extension of cellular lifespan, methods and reagents
10/28/1999WO1999021540B1 Method of reducing craving in mammals
10/28/1999WO1999004773A9 Method for inhibiting bone resorption
10/28/1999WO1997029739A3 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
10/28/1999DE19818696A1 Protection of organ, especially lung, transplants against rejection
10/28/1999DE19818044A1 Reducing side effects or neutralizing action of carcinostatic or immunosuppressive agents, especially pyridine derivatives, using vitamin PP compounds, e.g. nicotinamide
10/28/1999CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999CA2328949A1 Adhesive preparations
10/28/1999CA2328774A1 Method of treating interstitial cystitis with recombinant heparin-binding epidermal growth factor-like growth factor (hb-egf)
10/28/1999CA2328331A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
10/28/1999CA2328081A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999CA2325848A1 B-cell growth factor related protein
10/28/1999CA2325561A1 Combination therapy using nucleic acids and conventional drugs
10/28/1999CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999CA2324995A1 Methods and products related to metabolic interactions in disease
10/28/1999CA2294980A1 Method for the treatment of endotoxic shock in mammels
10/28/1999CA2270320A1 Novel microsphere composition
10/27/1999EP0951911A2 Method for administering aspb28-human insulin
10/27/1999EP0951910A2 Method for administering monomeric insulin analogs
10/27/1999EP0951903A1 Therapeutic treatment for renal dysfunction
10/27/1999EP0951568A1 Methods for detecting and inhibiting the rna component of telomerase
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951553A2 Adenovirus e4 proteins for inducing cell death
10/27/1999EP0951545A2 Human gtp-binding proteins
10/27/1999EP0951532A1 Bivalent agonists for g-protein coupled receptors
10/27/1999EP0951480A1 Method and novel compounds for use therein
10/27/1999EP0951474A1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
10/27/1999EP0951469A1 Novel compounds
10/27/1999EP0951300A1 Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
10/27/1999EP0951296A1 NOVEL FtsL
10/27/1999EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999EP0951293A1 Method for treating alzheimer's disease
10/27/1999EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/27/1999EP0951283A1 Novel arachidonic acid metabolite, 16-hete
10/27/1999EP0951282A1 Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists
10/27/1999EP0825856A4 Irritation relief using nonsteroidal anti-inflammatory compounds
10/27/1999CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999CN1233188A Medicines comprising Rho kinase inhibitor
10/27/1999CN1233180A Treatment of the common cold or allergic rhinitis
10/27/1999CN1233179A Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
10/27/1999CN1233177A Therapeutic treatment for VEGF related diseases
10/27/1999CN1233150A Method for inhibiting the expression of FAS
10/27/1999CN1232701A Process for preparing herbal compositions for treatment of bronchitis and respiratory disorders with anticancer properties
10/26/1999US5973111 Novel compounds that are capable of binding to the active site of interleukin-1b-converting enzyme (ice) and inhibiting activity of that enzyme; administering to treat inflammatory, autoimmune, and neurodegenerative diseases
10/26/1999US5973011 Administration of 6 mg/kg/day of an organic nitrate to an individual to maintain or improve endothelial function
10/26/1999US5973007 Use of inhibitors of retinoic acid activity for wound healing
10/26/1999US5972995 One or more flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues.
1 ... 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 ... 1151